Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 237-424-2 | CAS number: 13780-06-8
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Genetic toxicity: in vivo
Administrative data
- Endpoint:
- in vivo mammalian somatic cell study: cytogenicity / erythrocyte micronucleus
- Type of information:
- experimental study
- Adequacy of study:
- weight of evidence
- Study period:
- Not reported
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- test procedure in accordance with generally accepted scientific standards and described in sufficient detail
- Remarks:
- Good-quality study conducted according to the NTP test protocol, and to GLP. Some limitations in reporting detail.
Cross-reference
- Reason / purpose for cross-reference:
- reference to same study
Reference
- Endpoint:
- sub-chronic toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- weight of evidence
- Study period:
- 7 August - 7 November 1989
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- test procedure in accordance with generally accepted scientific standards and described in sufficient detail
- Remarks:
- Study conducted according to the NTP test protocol, and to GLP. Certain parameters (e.g. haematology, clinical chemistry, urinalysis, immunology and neuropathology) were not assessed.
- Reason / purpose for cross-reference:
- reference to same study
- Reason / purpose for cross-reference:
- reference to other study
- Reason / purpose for cross-reference:
- reference to other study
- Reason / purpose for cross-reference:
- reference to other study
- Qualifier:
- according to guideline
- Guideline:
- other: NTP 14-week study test method
- Deviations:
- no
- Principles of method if other than guideline:
- As part of the NTP investigation into the toxicology of sodium nitrite, 14-week and 2-year studies were conducted in both rats and mice, each differing in the extent of examination. In the 14-week mouse study, a number of routine examinations (e.g. haematology, clinical chemistry, urinalysis) were omitted from the assessment. Certain of these parameters were assessed elsewhere in the overall investigation (14-wk study in rats); an extensive histopathological assessment was conducted.
- GLP compliance:
- yes
- Limit test:
- no
- Species:
- mouse
- Strain:
- B6C3F1
- Details on species / strain selection:
- No data, though B6C3F1 mice are often used by the NTP in repeated dose studies
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Taconic Farms (Germantown, NY)
- Age at study initiation: 6 weeks
- Weight at study initiation: no data
- Assigned to test groups randomly: Animals were distributed randomly into groups of approximately equal initial mean body weights
- Fasting period before study: no data
- Housing: Solid-bottom polycarbonate cages (1 animal/cage), changed weekly; rotated every 2 weeks
- Diet (e.g. ad libitum): NIH-07 open formula powdered diet, available ad libitum, changed weekly
- Water (e.g. ad libitum): Charcoal-filtered deionized water, available ad libitum and changed twice weekly
- Acclimation period: 11 days
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 72 ± 3°F (20.6-23.9°C)
- Humidity (%): 50 ± 15%
- Air changes (per hr): ≥10
- Photoperiod (hrs dark / hrs light): 12/12
IN-LIFE DATES: From: 7 August 1989 To: 6 November 1989 (males) and 7 November 1989 (females) - Route of administration:
- oral: drinking water
- Vehicle:
- water
- Details on oral exposure:
- - PREPARATION OF DOSING SOLUTIONS: The dose formulations were prepared every 2 weeks by mixing sodium nitrite with water
- VEHICLE
- Justification for use and choice of vehicle (if other than water): not applicable
- Concentration in vehicle: not applicable
- Purity: no data - Analytical verification of doses or concentrations:
- yes
- Details on analytical verification of doses or concentrations:
- Stability studies of a 0.075 mg/mL dose formulation were performed by the analytical chemistry laboratory using ultraviolet/visible spectrophotometry by measuring absorbance at 347 nm of an aliquot of the sample treated with a salt solution (sodium sulfate and sodium acetate) and a colour reagent (hydrochloric acid, resorcinol and zinconyl chloride). Stability was confirmed for at least 35 days for dose formulations stored at 5oC or at room temperature in the dark.
- Duration of treatment / exposure:
- 14 weeks
- Frequency of treatment:
- Continuously
- Dose / conc.:
- 375 ppm
- Remarks:
- Equivalent to approximately 90 mg/kg bw/day (males) and 120 mg/kg bw/day (females).
- Dose / conc.:
- 750 ppm
- Remarks:
- Equivalent to approximately 190 mg/kg bw/day (males) and 240 mg/kg bw/day (females).
- Dose / conc.:
- 1 500 ppm
- Remarks:
- Equivalent to approximately 345 mg/kg bw/day (males) and 445 mg/kg bw/day (females).
- Dose / conc.:
- 3 000 ppm
- Remarks:
- Equivalent to approximately 650 mg/kg bw/day (males) and 840 mg/kg bw/day (females).
- Dose / conc.:
- 5 000 ppm
- Remarks:
- Equivalent to approximately 990 mg/kg bw/day (males) and 1230 mg/kg bw/day (females).
- No. of animals per sex per dose:
- 10
- Control animals:
- yes, concurrent vehicle
- Details on study design:
- - Dose selection rationale:
- Rationale for animal assignment (if not random): not applicable
- Rationale for selecting satellite groups: not applicable
- Post-exposure recovery period in satellite groups: not applicable
- Section schedule rationale (if not random): no data - Positive control:
- none
- Observations and examinations performed and frequency:
- CAGE SIDE OBSERVATIONS: Yes (not further specified)
- Time schedule: twice daily
DETAILED CLINICAL OBSERVATIONS: Yes
- Time schedule: weekly
BODY WEIGHT: Yes
- Time schedule for examinations: weekly
FOOD CONSUMPTION AND COMPOUND INTAKE (if feeding study):
- Food consumption for each animal determined and mean daily diet consumption calculated as g food/kg body weight/day: Yes (weekly)
- Compound intake calculated as time-weighted averages from the consumption and body weight gain data: No
FOOD EFFICIENCY:
- Body weight gain in kg/food consumption in kg per unit time X 100 calculated as time-weighted averages from the consumption and body weight gain data: No
WATER CONSUMPTION AND COMPOUND INTAKE (if drinking water study): Yes
- Time schedule for examinations: drinking water consumption was measured daily
OPHTHALMOSCOPIC EXAMINATION: No t specified
HAEMATOLOGY: No
CLINICAL CHEMISTRY: No
URINALYSIS: Not specified
NEUROBEHAVIOURAL EXAMINATION: Not specified
IMMUNOLOGY: Not specified - Sacrifice and pathology:
- GROSS PATHOLOGY: Yes (not further specified)
HISTOPATHOLOGY: Yes. Complete histopathology was performed on 0 and 5000 ppm animals. In addition to gross lesions and tissue masses, the following tissues were examined: adrenal gland, bone and marrow, brain, clitoral gland, esophagus, heart, large intestine (cecum, colon, rectum), small intestine (duodenum, jejunum, ileum), kidney, liver, lung, lymph nodes (mandibular and mesenteric), mammary gland, muscle, nose, ovary, pancreas, parathyroid gland, pituitary gland, preputial gland, prostate gland, salivary gland, spleen, skin, stomach (forestomach and glandular), testis (and epididymis and seminal vesicle), thymus, thyroid gland, trachea, urinary bladder, and uterus. The forestomach, testis and spleen of all remaining mice were also examined
OTHER: Organs weighed were heart, right kidney, liver, lung, spleen, right testis, and thymus. - Other examinations:
- At the end of the studies, samples were collected for sperm motility or vaginal cytology evaluations from mice in the 0, 375, 1500 and 5000 ppm groups. The left cauda, epididymis, and testis were weighed. The following parameters were evaluated: spermatid heads per gram testis, spermatid heads per testis, spermatid count, motility, and concentration. Vaginal samples were collected for up to 12 consecutive days prior to the end of the studies for vaginal cytology evaluations. The length of the estrous cycle and the length of time spent in each stage of the cycle were evaluated.
- Statistics:
- The probability of survival was estimated by the product-limit procedure of Kaplan and Meier (1958). Statistical analyses used Cox’s (1972) method for testing two groups for equality and Tarone’s (1975) life table test to identify dose-related trends. All reported P values for the survival analyses are two sided.
The Poly-k test (Bailer and Portier, 1988; Portier and Bailer, 1989; Piegorsch and Bailer, 1997) was used to assess (non)neoplastic lesion prevalence. Unless otherwise specified, a value of k=3 was used in the analysis of site-specific lesions. Tests of significance included pairwise comparisons of each exposed group with controls and a test for an overall exposure-related trend. Continuity-corrected Poly-3 tests were used, and reported P values are one sided. Values of P greater than 0.5 are presented as 1 - P with the letter N added to indicate a lower incidence or negative trend in neoplasm occurrence relative to the control group (e.g., P=0.99 is presented as P=0.01N).
Organ and body weight data (continuous variables) were analysed with the parametric multiple comparison procedures of Dunnett (1955) and Williams (1971, 1972). Spermatid and epididymal spermatozoal data were analysed using the nonparametric multiple comparison methods of Shirley (1977) and Dunn (1964). Jonckheere’s test (Jonckheere, 1954) was used to assess the significance of the dose-related trends and to determine whether a trend-sensitive test (Williams’ or Shirley’s test) was more appropriate for pairwise comparisons than a test that does not assume a monotonic dose-related trend (Dunnett’s or Dunn’s test). - Clinical signs:
- no effects observed
- Description (incidence and severity):
- There were no chemical-related clinical findings; no cyanosis or brownish discoloration was observed.
- Mortality:
- no mortality observed
- Description (incidence):
- All mice survived until the end of the study.
- Body weight and weight changes:
- effects observed, treatment-related
- Description (incidence and severity):
- Final mean body weights and growth of 990 mg/kg bw/day males and growth of 650 mg/kg bw/day males were significantly less than those of the controls.
A not statistically-significant reduction in final mean body weights and growth was seen in high-dose females.
It was considered that reduced water consumption may have been responsible for the observed growth effects through decreased feed consumption. - Food consumption and compound intake (if feeding study):
- not specified
- Food efficiency:
- not examined
- Water consumption and compound intake (if drinking water study):
- effects observed, treatment-related
- Description (incidence and severity):
- Water consumption in males (at and above 345 mg/kg bw/day) was less than that of controls at week 13.
- Ophthalmological findings:
- not examined
- Haematological findings:
- not examined
- Clinical biochemistry findings:
- not examined
- Urinalysis findings:
- not examined
- Behaviour (functional findings):
- not examined
- Immunological findings:
- not examined
- Organ weight findings including organ / body weight ratios:
- effects observed, treatment-related
- Description (incidence and severity):
- Relative and absolute spleen weights of males were significantly (P ≤ 0.01) greater than those of the controls at the highest dose level (990 mg/kg bw/day) [relative spleen weight was statistically significantly (P ≤ 0.01) increased in males at 650 mg/kg bw/day]. Males in the highest dose group also displayed statistically significant increases in relative heart, kidney and testes weights.
Relative (and absolute) heart, kidney, liver and spleen weights were also significantly increased in females at the highest tested dose level (1230 mg/kg bw/day). Similarly, females in the 840 mg/kg bw/day group showed increased relative and absolute liver and spleen weights, as well as absolute heart and kidney weights. - Gross pathological findings:
- no effects observed
- Neuropathological findings:
- not examined
- Histopathological findings: non-neoplastic:
- effects observed, treatment-related
- Description (incidence and severity):
- Squamous cell hyperplasia of the forestomach was apparent in animals at the highest tested dose (990 and 1230 for males and females, respectively). The incidences of extramedullary hematopoiesis in the spleen of males (650 and 990 mg/kg bw/day) and females (at and above 445 mg/kg bw/day) were significantly greater than those in the control groups. Males exposed at the two highest dose levels also showed significantly increased incidences of degeneration of the testis.
- Histopathological findings: neoplastic:
- not examined
- Other effects:
- effects observed, treatment-related
- Description (incidence and severity):
- Sperm motility in 990 mg/kg bw/day males was decreased relative to the controls and the estrous cycles of 445 and 1230 mg/kg bw/day females were significantly longer than those of the controls
- Details on results:
- The brownish discoloration and cyanosis seen in rats were not observed in mice. The authors noted that mice may have a higher erythrocyte methaemoglobin reductase activity than do rats, and this was considered a possible explanation for the observed inter-species differences. Increased relative spleen weights occurred in both sexes at the two highest dose levels, and increased splenic extramedullary hematopoiesis was observed. Since the spleen is an erythropoietically active tissue in adult mice, the observed splenic extramedullary hematopoiesis was considered to be consistent with methaemoglobin formation and tissue hypoxia.
The EFSA Panel considered that "tissue hypoxia due to methaemoglobin formation is a strong signal to elicit extramedullary haematopoiesis". Based on extramedullary haematopoiesis in the spleen consistent with methaemoglobin formation, the Panel identified respective NOAELs of 345 and 240 mg/kg bw/day for males and females. - Dose descriptor:
- NOAEL
- Effect level:
- 345 mg/kg bw/day (nominal)
- Based on:
- test mat.
- Sex:
- male
- Basis for effect level:
- histopathology: non-neoplastic
- Remarks on result:
- other:
- Remarks:
- This value was established by EFSA following a recent review of the data.
- Dose descriptor:
- NOAEL
- Effect level:
- 240 mg/kg bw/day (nominal)
- Based on:
- test mat.
- Sex:
- female
- Basis for effect level:
- histopathology: non-neoplastic
- Remarks on result:
- other:
- Remarks:
- This value was established by EFSA following a recent review of the data.
- Critical effects observed:
- not specified
- Conclusions:
- In a NTP subchronic oral toxicity study, sodium nitrite was provided to mice (10/sex/group) in the drinking water at 375, 750, 1500, 3000 or 5000 ppm (equivalent to approximate dose levels of 90, 190, 345, 650 or 990 mg/kg bw/day for males and 120, 240, 445, 840 or 1230 mg/kg bw/day for females) for 14 weeks. Based on an increased incidence of extramedullary haematopoiesis in the spleen of both sexes, EFSA established NOAELs of 345 and 240 mg/kg bw/day for males and females respectively.
- Executive summary:
In a NTP subchronic oral toxicity study, conducted according to the NTP test protocol and to GLP, sodium nitrite was provided to B6C3F1 mice (10/sex/group) in the drinking water at 375, 750, 1500, 3000 or 5000 ppm (equivalent to approximate dose levels of 90, 190, 345, 650 or 990 mg/kg bw/day for males and 120, 240, 445, 840 or 1230 mg/kg bw/day for females) for 14 weeks. Control animals received vehicle only. Parameters evaluated included mortality, clinical observations, body weight, water consumption, sperm motility, vaginal cytology, selected organ weights, gross and histopathologic examination.
No clinical signs of toxicity, mortality or gross lesions were apparent following treatment with sodium nitrite. At the highest two dose levels, males displayed reduced growth while organ weights (heart, kidney, liver, spleen [and testis]) tended to show statistically significant increases in both sexes; generally, there were no concurrent adverse histopathological findings. Upon microscopic assessment, squamous cell hyperplasia of the forestomach was observed in animals at the highest tested dose along with increased incidence of testis degeneration in males at and above 650 mg/kg bw/day. Increased incidence of extramedullary haematopoiesis in the spleen was also observed in males at these dose levels and in females from 445 mg/kg bw/day. Reduced sperm motility was evident in 990 mg/kg bw/day males and the estrous cycles of 445 and 1230 mg/kg bw/day females were significantly longer than those of the controls.
The EFSA Panel considered the increased incidence of extramedullary haematopoiesis in the spleen, consistent with methaemoglobin formation and tissue hypoxia, to be the critical effect, establishing NOAELs of 345 and 240 mg/kg bw/day for males and females respectively.
Data source
Reference
- Reference Type:
- publication
- Title:
- Unnamed
- Year:
- 2 001
- Report date:
- 2001
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- other: Mouse peripheral blood micronucleus NTP test protocol
- Version / remarks:
- As described by MacGregor et al. (1990).
MacGregor JT, Wehr CM, Henika PR and Shelby MD (1990). The in vivo erythrocyte micronucleus test: Measurement at steady state increases assay efficiency and permits integration with toxicity studies. Fundam. Appl. Toxicol. 14, 513-522. - Deviations:
- no
- GLP compliance:
- yes
- Type of assay:
- mammalian erythrocyte micronucleus test
Test material
- Reference substance name:
- Sodium nitrite
- EC Number:
- 231-555-9
- EC Name:
- Sodium nitrite
- Cas Number:
- 7632-00-0
- Molecular formula:
- HNO2.Na
- IUPAC Name:
- sodium nitrite
- Test material form:
- solid: crystalline
Constituent 1
Test animals
- Species:
- mouse
- Strain:
- B6C3F1
- Details on species / strain selection:
- No data
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Taconic Farms (Germantown, NY)
- Age at study initiation: 6 weeks
- Weight at study initiation: no data
- Assigned to test groups randomly: Animals were distributed randomly into groups of approximately equal initial mean body weights
- Fasting period before study: no data
- Housing: Solid-bottom polycarbonate cages (1 animal/cage), changed weekly; rotated every 2 weeks
- Diet (e.g. ad libitum): NIH-07 open formula powdered diet, available ad libitum, changed weekly
- Water (e.g. ad libitum): Charcoal-filtered deionized water, available ad libitum and changed twice weekly
- Acclimation period: 11 days
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 72 ± 3°F (20.6-23.9°C)
- Humidity (%): 50 ± 15%
- Air changes (per hr): ≥10
- Photoperiod (hrs dark / hrs light): 12/12
IN-LIFE DATES: From: 7 August 1989 To: 6 November 1989 (males) and 7 November 1989 (females)
Administration / exposure
- Route of administration:
- oral: drinking water
- Vehicle:
- - Vehicle(s)/solvent(s) used: water
- Justification for choice of solvent/vehicle: no data
- Concentration of test material in vehicle: 375, 750, 1500, 3000 or 5000 ppm
- Purity: no data - Details on exposure:
- PREPARATION OF DOSING SOLUTIONS: The dose formulations were prepared every 2 weeks by mixing sodium nitrite with water
- Duration of treatment / exposure:
- 14 weeks
- Frequency of treatment:
- Continuously
- Post exposure period:
- None (peripheral blood sampling/necropsy on day of last exposure)
Doses / concentrationsopen allclose all
- Dose / conc.:
- 375 ppm
- Remarks:
- Equivalent to approximately 90 mg/kg bw/day (males) and 120 mg/kg bw/day (females).
- Dose / conc.:
- 750 ppm
- Remarks:
- Equivalent to approximately 190 mg/kg bw/day (males) and 240 mg/kg bw/day (females).
- Dose / conc.:
- 1 500 ppm
- Remarks:
- Equivalent to approximately 345 mg/kg bw/day (males) and 445 mg/kg bw/day (females).
- Dose / conc.:
- 3 000 ppm
- Remarks:
- Equivalent to approximately 750 mg/kg bw/day (males) and 840 mg/kg bw/day (females).
- Dose / conc.:
- 5 000 ppm
- Remarks:
- Equivalent to approximately 990 mg/kg bw/day (males) and 1230 mg/kg bw/day (females).
- No. of animals per sex per dose:
- 10
- Control animals:
- yes, concurrent vehicle
Examinations
- Tissues and cell types examined:
- Normochromatic erythrocytes (NCEs) from peripheral blood
- Details of tissue and slide preparation:
- CRITERIA FOR DOSE SELECTION: mice from all treatment groups were scored for micronuclei
TREATMENT AND SAMPLING TIMES (in addition to information in specific fields): At the end of the 14-week treatment period, peripheral blood samples were obtained from 10 male and 10 female mice per group.
DETAILS OF SLIDE PREPARATION: Smears were immediately prepared and fixed in absolute methanol. The methanol-fixed slides were stained with acridine orange and coded.
METHOD OF ANALYSIS: Slides were scanned to determine the frequency of micronuclei in 2000 normochromatic erythrocytes (NCEs) in each of 10 animals per exposure group. - Evaluation criteria:
- An experiment is considered positive if the trend test P value is less than or equal to 0.025 or if the P value for any single dosed group is less than or equal to 0.025 divided by the number of dosed groups (i.e. P ≤ 0.005 for males and females).
- Statistics:
- Mean numbers of micronucleated NCEs (per 1000 NCEs) were calculated along with standard errors. Significance of micronucleated NCEs/1000 NCEs tested by the one-tailed trend test.
Results and discussion
Test results
- Key result
- Sex:
- male/female
- Genotoxicity:
- negative
- Toxicity:
- yes
- Remarks:
- Extramedullary haematopoiesis observed in the spleen of males and females exposed at and above respective nominal concentrations of 3000 and 1500 ppm; males also displayed testes degeneration at the two highest concentrations
- Vehicle controls validity:
- not specified
- Negative controls validity:
- not applicable
- Positive controls validity:
- not applicable
- Additional information on results:
- No significant (or dose-related) increase in the frequency of micronucleated NCEs was observed in the treated groups, compared to the control animals. As such, there was no indication of chromosome damage in this test.
Applicant's summary and conclusion
- Conclusions:
- A mammalian erythrocyte micronucleus test was conducted (according to the NTP test protocol) using animals from a 14-week GLP repeated dose oral toxicity study on sodium nitrite in mice. No significant increase in the frequency of micronuclei in peripheral blood were reported following administration of sodium nitrite via drinking water at concentrations of up to 5000 ppm (respective dose levels of 990 and 1230 mg/kg bw/day for males and females).
- Executive summary:
A mammalian erythrocyte micronucleus test was conducted according to the NTP test protocol using animals from a GLP subchronic oral toxicity study. In the main repeated dose study, sodium nitrite was administered daily via drinking water to mice (10/sex/group) at 375, 750, 1500, 3000 or 5000 ppm (equivalent to approximate dose levels of 90, 190, 345, 750 or 990 mg/kg bw/day for males and 120, 240, 445, 840 or 1230 mg/kg bw/day for females) for 14 weeks. Control animals received vehicle only. Peripheral blood samples were obtained at the end of the treatment period, fixed and stained prior to analysis. The frequency of micronuclei in 2000 normochromatic erythrocytes (NCEs) was calculated.
No significant increase in the frequency of micronucleated NCEs was observed in any of the treated dose groups. Extramedullary haematopoiesis was observed in the spleen of males and females exposed at and above respective nominal concentrations of 3000 and 1500 ppm, while males also displayed testes degeneration at the two highest concentrations [See Repeated dose toxicity section for details].
It is concluded that sodium nitrite failed to induce an increase in the frequency of micronuclei in the blood of mice following administration via drinking water at concentrations of up to 5000 ppm (about 990-1230 mg/kg bw/day in males and females respectively) for 14 weeks.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.